Low-dose lithium may slow kidney aging
Best known therapeutically as a treatment for bipolar disorder, lithium has long intrigued researchers with its potential age-defying properties.
Apr 11, 2022
0
18
Best known therapeutically as a treatment for bipolar disorder, lithium has long intrigued researchers with its potential age-defying properties.
Apr 11, 2022
0
18
Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a multifaceted strategy to try to keep their blood pressure from dropping to a potentially dangerous low level immediately before, ...
Apr 4, 2022
0
4
More than 40% of hospitalized individuals with COVID-19 have diabetes. But why is having diabetes a major risk factor for a more serious COVID-19 illness? Researchers now are starting to put the puzzle together.
Apr 4, 2022
0
4
Some people recovering from COVID-19 pneumonia have CT evidence of damage to their lungs that persists a full year after the onset of symptoms, according to a new study published in the journal Radiology.
Mar 29, 2022
0
21
Additional doses of COVID-19 vaccine are recommended for immunocompromised patients, especially for organ transplant recipients who are least able to make antibodies to fight off coronavirus, say experts in The BMJ today.
Mar 2, 2022
0
10
(HealthDay)—The pooled prevalence of primary sclerosing cholangitis (PSC) is 2.16 percent in patients with inflammatory bowel disease (IBD), according to a review published in the December issue of Gastroenterology.
Nov 24, 2021
0
1
Colchicine, a cheap anti-inflammatory drug normally used to treat gout, doesn't lessen COVID-19 severity or stave off the risk of death from the infection in hospital patients, finds a pooled analysis of the available evidence, ...
Nov 22, 2021
0
7
A major study has found that convalescent plasma does not reduce the risk of intubation or death for COVID-19 patients. However, the study also revealed that the antibody profile in the blood of people who have had the virus ...
Sep 9, 2021
0
209
In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab—two monoclonal antibody treatments under Food and Drug Administration emergency use authorization—keep high-risk ...
Aug 30, 2021
0
76
Heart failure patients aged 80 and above are less likely to receive recommended therapies and dosages compared to their younger counterparts, according to research presented today at Heart Failure 2021, an online scientific ...
Jul 1, 2021
0
5